Deep vein thrombosis (DVT) is a major origin of morbidity and mortality. While DVT has long
been considered as blood coagulation disorder, several recent lines of evidence …

The inflammatory response is a well-established part of, and a prerequisite for, venous
thrombosis. To better understand the pathophysiology of venous thrombosis and to identify …

Essentials• PSGL‐1+ microvesicles (MVs) may be important in venous thromboembolism
(VTE).• We measured plasma levels and parental origin of PSGL‐1+ MVs in patients with …

The development of deep venous thrombosis (DVT) is a sterile inflammatory process related
to cytokines, such as interleukin (IL)-6 or IL-17. IL-9 is a cytokine involved in many …

Context: One approach to reducing the harm caused by cigarette smoking, at both individual
and population level, is to develop, assess and commercialize modified risk alternatives that …

Patients with gastric cancer (GC) are at higher risk of thromboembolism when compared to
other solid tumors. We aim to determine the predictive performance of current venous …

Background Due to the discovery that deep venous thrombosis (DVT) inhibitor is of
chemotherapeutic importance, the nano-property of dimethyl 2, 2′-[2, 2′-(ethane-1, 1-diyl) …

Venous thromboembolic disease (VTE) remains a significant source of morbidity and
mortality. As non-specific subjective complaints and a paucity of objective clinical …

Background: Venous thromboembolic disease (VTE) remains a significant source of
morbidity and mortality. As non-specific subjective complaints and a lack of objective clinical …

Background: Pediatric hospital-acquired venous thromboembolism (HA-VTE) has increased
over the past ten years, with central venous catheters (CVC) being the strongest risk factor …